Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vaxcyte, Inc. | SVP, FINANCE | Common Stock | 11.6K | $1.28M | $110.15 | Sep 3, 2024 | Direct |
Vaxcyte, Inc. | SVP, FINANCE | Stock Option (right to buy) | 114K | Sep 3, 2024 | Direct | ||
Vaxcyte, Inc. | SVP, FINANCE | Performance Stock Option (right to buy) | 11.9K | Nov 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PCVX | Vaxcyte, Inc. | Nov 7, 2024 | 1 | $0 | 4 | Nov 8, 2024 | SVP, FINANCE |
PCVX | Vaxcyte, Inc. | Sep 3, 2024 | 4 | -$535K | 4 | Sep 5, 2024 | SVP, FINANCE |
PCVX | Vaxcyte, Inc. | Jul 16, 2024 | 3 | -$295K | 4 | Jul 17, 2024 | SVP, FINANCE |
PCVX | Vaxcyte, Inc. | Jul 8, 2024 | 3 | -$270K | 4 | Jul 9, 2024 | SVP, FINANCE |
PCVX | Vaxcyte, Inc. | Feb 29, 2024 | 8 | -$603K | 4 | Mar 4, 2024 | SVP, FINANCE |
PCVX | Vaxcyte, Inc. | Sep 5, 2023 | 1 | -$32K | 4 | Sep 6, 2023 | SVP, Finance |
PCVX | Vaxcyte, Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | SVP, Finance |
PCVX | Vaxcyte, Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 4, 2023 | SVP, Finance and Principal Accounting Officer |